A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Oh, Jin Kyun
Kim, Angela H
Jenny, Laura A
Tsang, Stephen H
Journal titleJCI insight
MetadataShow full item record
AbstractHere, we describe affected members of a 2-generation family with a Stargardt disease-like phenotype caused by a 2-base pair deletion insertion, c.1014_1015delGAinsCT;p.(Trp338_Asn339delinsCysTyr), in BEST1. The variant was identified by whole-exome sequencing, and its pathogenicity was verified through chloride channel recording using WT and transfected mutant HEK293 cells. Clinical examination of both patients revealed similar phenotypes at 2 different disease stages that were attributable to differences in their age at presentation. Hyperautofluorescent flecks along the arcades were observed in the proband, while the affected mother exhibited more advanced retinal pigment epithelium (RPE) loss in the central macula. Full-field electroretinogram testing was unremarkable in the daughter; however, moderate attenuation of generalized cone function was detected in the mother. Results from electrooculogram testing in the daughter were consistent with widespread dysfunction of the RPE characteristic of Best disease. Whole-cell patch-clamp recordings revealed a statistically significant decrease in chloride conductance of the mutant compared with WT cells. This report on a mother and daughter with a BEST1 genotype that phenocopies Stargardt disease broadens the clinical spectrum of BEST1-associated retinopathy.
CitationKolesnikova M, Oh JK, Wang J, Lee W, Zernant J, Su PY, Kim AH, Jenny LA, Yang T, Allikmets R, Tsang SH. A pathogenic in-frame deletion-insertion variant in BEST1 phenocopies Stargardt disease. JCI Insight. 2022 Dec 8;7(23):e162687. doi: 10.1172/jci.insight.162687. PMID: 36264634; PMCID: PMC9746905.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Distinct expression requirements and rescue strategies for BEST1 loss- and gain-of-function mutations.
- Authors: Zhao Q, Kong Y, Kittredge A, Li Y, Shen Y, Zhang Y, Tsang SH, Yang T
- Issue date: 2021 Jun 1
- A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1.
- Authors: Wood SR, McClements ME, Martinez-Fernandez de la Camara C, Patrício MI, Uggenti C, Sekaran S, Barnard AR, Manson FD, MacLaren RE
- Issue date: 2019 Apr
- Genetic and clinical features of BEST1-associated retinopathy based on 59 Chinese families and database comparisons.
- Authors: Wang Y, Jiang Y, Li X, Xiao X, Li S, Sun W, Wang P, Zhang Q
- Issue date: 2022 Oct
- Phenotype-genotype correlations in a pseudodominant Stargardt disease pedigree due to a novel ABCA4 deletion-insertion variant causing a splicing defect.
- Authors: Huang D, Thompson JA, Charng J, Chelva E, McLenachan S, Chen SC, Zhang D, McLaren TL, Lamey TM, Constable IJ, De Roach JN, Aung-Htut MT, Adams A, Fletcher S, Wilton SD, Chen FK
- Issue date: 2020 Jul
- Pathogenicity of new BEST1 variants identified in Italian patients with best vitelliform macular dystrophy assessed by computational structural biology.
- Authors: Frecer V, Iarossi G, Salvetti AP, Maltese PE, Delledonne G, Oldani M, Staurenghi G, Falsini B, Minnella AM, Ziccardi L, Magli A, Colombo L, D'Esposito F, Miertus J, Viola F, Attanasio M, Maggio E, Bertelli M
- Issue date: 2019 Oct 1